[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine

[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine

Abstract Aim The objective of this study was to compare the detection rates of [18F]PSMA-1007 and [18F]Fluciclovine in early biochemical recurrence (BCR) of prostate cancer, i.e. with low prostate-specific antigen (PSA) levels (0.2–5.0 µg/L). Methods This was a prospective, single-center (Radboudumc...

Full description

Bibliographic Details
Main Authors: Cato C. Loeff, Willemijn van Gemert, Bastiaan M. Privé, Inge M. van Oort, Rick Hermsen, Diederik M. Somford, James Nagarajah, Linda Heijmen, Marcel J. R. Janssen
Format: Article
Language:English
Published: Springer 2024-11-01
Series:EJNMMI Reports
Subjects:
PET/CT
PSMA
Fluciclovine
Biochemical recurrence
Prostate cancer (PCa)
Online Access:https://doi.org/10.1186/s41824-024-00228-2

Internet

https://doi.org/10.1186/s41824-024-00228-2

Similar Items